Re-usable capmats offer increased chemical resistance
The silicone capmats reseal after each piercing and may be re-pierced many times without loss of function.
Porvair Sciences has launched a new range of 96-well (square and round) capmats made from 100% pure silicone that has been conditioned for low bleed and ease of needle penetration when used with autosamplers. Advantageously these silicone capmats reseal after each piercing and may be re-pierced many times without loss of function.
Specially treated with a PTFE coating, Porvair silicone capmats offer increased chemical resistance thereby maintaining high sample integrity even over extended periods of time. Resistant to organic solvents including ethanol, methanol, DMSO and DMF, these flexible silicone capmats individually seal the top of each microplate well reducing the chance of well-to-well sample contamination to near zero. Stable over a wide temperature range – Porvair silicone capmats may be autoclaved clean at 120 °C or used to provide high integrity store down to -70 °C.
In addition to its range of re-usable capmats, Porvair Sciences offers a comprehensive range of seals and foils for thermal and adhesive sealing of microplates.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.